Skip to content

Clinical trials

Phase 1/2 Anemia, Sickle Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 1/2 Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20072
20084
20095
20113
20122
20133
20144
20152
20162
20172
20183
20191
20204
20213
20223
20233
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated11
Active, not recruiting10
Recruiting10
Withdrawn4
Enrolling by invitation1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
Children's Hospital Los Angeles2
Diane George2
Gamida Cell ltd2
Talaris Therapeutics Inc.2
UCSF Benioff Children's Hospital Oakland2
University of Illinois at Chicago2
Albert Einstein College of Medicine1
Ann & Robert H Lurie Children's Hospital of Chicago1
Arkansas Children's Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell59
beta-Thalassemia7
Hemoglobinopathies6
Thalassemia6
Anemia, Diamond-Blackfan5
Bone Marrow Failure Disorders5
Genetic Diseases, Inborn5
Anemia4
Anemia, Aplastic3
Anemia, Hemolytic3

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.